Cargando…

A neonatal murine model of coxsackievirus A4 infection for evaluation of vaccines and antiviral drugs

Coxsackievirus A4 (CVA4) infection can cause hand, foot and mouth disease (HFMD), an epidemic illness affecting neonatal and paediatric cohorts, which can develop to severe neurological disease with high mortality. In this study, we established the first ICR mouse model of CVA4 infection for the eva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhenjie, Zhang, Xingcheng, Carr, Michael J., Zhou, Hong, Li, Juan, Liu, Shaoqiong, Liu, Tao, Xing, Weijia, Shi, Weifeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6792045/ https://www.ncbi.nlm.nih.gov/pubmed/31595827 http://dx.doi.org/10.1080/22221751.2019.1673135

Ejemplares similares

Neonatal Murine Model of Coxsackievirus A2 Infection for the Evaluation of Antiviral Therapeutics and Vaccination
por: Ji, Wangquan, et al.
Publicado: (2021)

A 10-Day-Old Murine Model of Coxsackievirus A6 Infection for the Evaluation of Vaccines and Antiviral Drugs
por: Jiang, Zaixue, et al.
Publicado: (2021)

An outbreak of a novel recombinant Coxsackievirus A4 in a kindergarten, Shandong province, China, 2021
por: Li, Juan, et al.
Publicado: (2022)

Development of A Neonatal Mouse Model for Coxsackievirus B1 Antiviral Evaluation
por: Yin, Zhichao, et al.
Publicado: (2021)

Coxsackievirus A6 Infection Causes Neurogenic Pathogenesis in a Neonatal Murine Model
por: Sun, Qiang, et al.
Publicado: (2023)

Antiviral Effects of Menthol on Coxsackievirus B
por: Taylor, David J.R., et al.
Publicado: (2020)

Murine model of acute myocarditis and cerebral cortical neuron edema induced by coxsackievirus B4
por: Dong, Zhao-Peng, et al.
Publicado: (2018)

Housekeeping Gene Expression in the Fetal and Neonatal Murine Thymus Following Coxsackievirus B4 Infection
por: Halouani, Aymen, et al.
Publicado: (2020)

Pharmacological and Biological Antiviral Therapeutics for Cardiac Coxsackievirus Infections
por: Fechner, Henry, et al.
Publicado: (2011)

The antiviral effect of jiadifenoic acids C against coxsackievirus B3
por: Ge, Miao, et al.
Publicado: (2014)

Coxsackievirus A2 Leads to Heart Injury in a Neonatal Mouse Model
por: Ji, Wangquan, et al.
Publicado: (2021)

Antiviral and immunoregulatory effects of curcumin on coxsackievirus B3-infected hepatitis
por: Lin, Yu-Jheng, et al.
Publicado: (2023)

Coxsackievirus B4 vertical transmission in a murine model
por: Jaïdane, Hela, et al.
Publicado: (2017)

Protection from lethal challenge in a neonatal mouse model by circulating recombinant form coxsackievirus A16 vaccine candidates
por: Li, Jingliang, et al.
Publicado: (2014)

Induction of cytopathic effect and cytokines in coxsackievirus B3-infected murine astrocytes
por: Zeng, Jun, et al.
Publicado: (2013)

Optimization and Characterization of Candidate Strain for Coxsackievirus A16 Inactivated Vaccine
por: Li, Jingliang, et al.
Publicado: (2015)

Antiviral and myocyte protective effects of IL-28A in coxsackievirus B3-induced myocarditis
por: Wang, Shihong, et al.
Publicado: (2014)

Antiviral activity of Bifidobacterium adolescentis SPM1605 against Coxsackievirus B3
por: Kim, Min Ji, et al.
Publicado: (2014)

Antiviral Activity of Chrysin Derivatives against Coxsackievirus B3 in vitro and in vivo
por: Song, Jae-Hyoung, et al.
Publicado: (2015)

Protein modification with ISG15 blocks coxsackievirus pathology by antiviral and metabolic reprogramming
por: Kespohl, Meike, et al.
Publicado: (2020)

Novel Antiviral Activity of Ethyl 3-Hydroxyhexanoate Against Coxsackievirus B Infection
por: Olasunkanmi, Oluwatayo Israel, et al.
Publicado: (2022)

Neonatal hand, foot, and mouth disease due to coxsackievirus A6 in Shanghai
por: Xu, Shanshan, et al.
Publicado: (2020)

Genome Analysis of Coxsackievirus A4 Isolates From Hand, Foot, and Mouth Disease Cases in Shandong, China
por: Wang, Min, et al.
Publicado: (2019)

Heart-specific autoantibodies following murine coxsackievirus B3 myocarditis
Publicado: (1985)

Antiviral Ability of Kalanchoe gracilis Leaf Extract against Enterovirus 71 and Coxsackievirus A16
por: Wang, Ching-Ying, et al.
Publicado: (2012)

Vaccines against Group B Coxsackieviruses and Their Importance
por: Mone, Kiruthiga, et al.
Publicado: (2023)

Antiviral activity of ginsenosides against coxsackievirus B3, enterovirus 71, and human rhinovirus 3
por: Song, Jae-Hyoung, et al.
Publicado: (2014)

Astragaloside IV reduces cardiomyocyte apoptosis in a murine model of coxsackievirus B3-induced viral myocarditis
por: Liu, Tianlong, et al.
Publicado: (2019)

Comparative pathogenicity of Coxsackievirus A16 circulating and noncirculating strains in vitro and in a neonatal mouse model
por: Huang, L., et al.
Publicado: (2015)

Evaluation of the cross-neutralization activities elicited by Coxsackievirus A10 vaccine strains
por: Huo, Yaqian, et al.
Publicado: (2021)

Chromosome Y Regulates Survival Following Murine Coxsackievirus B3 Infection
por: Case, Laure K., et al.
Publicado: (2012)

Electrophysiological alterations in a murine model of chronic coxsackievirus B3 myocarditis
por: Kaese, Sven, et al.
Publicado: (2017)

A cysteine protease inhibitor GC376 displays potent antiviral activity against coxsackievirus infection
por: Chen, Yongkang, et al.
Publicado: (2023)

Etymologia: Coxsackievirus
Publicado: (2012)

COXSACKIEVIRUSES (PICORNAVIRIDAE)
por: Pozzetto, Bruno, et al.
Publicado: (1999)

Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of coxsackievirus b3-induced viral myocarditis reduces myocardium inflammation
por: Fan, Yang, et al.
Publicado: (2011)

CEACAM-1 promotes myocardial injury following coxsackievirus infection by regulating the coxsackievirus-adenovirus receptor
por: Zhang, Zaiyong, et al.
Publicado: (2019)

Peculiar Clinical Presentation of Coxsackievirus B4 Infection: Neonatal Restrictive Cardiomyopathy
por: Le Van Quyen, Pauline, et al.
Publicado: (2017)

Molecular Epidemiology Reveals the Co-Circulation of Two Genotypes of Coxsackievirus B5 in China
por: He, Yun, et al.
Publicado: (2022)

Molecular mechanism of antibody neutralization of coxsackievirus A16
por: Zhang, Chao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_505fhrp9ssdj49ovd8n95p43j1